Categories: News

Inogen to Announce First Quarter 2021 Financial Results on May 4th, 2021

GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2021 financial results after market close on Tuesday, May 4th, 2021. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689-8589 for international callers. Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen’s website at: http://investor.inogen.com/.

A replay of the call will be available beginning May 4th, 2021 at 3:30pm PT/6:30pm ET through 3:30pm PT/6:30pm ET on May 18th, 2021. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13718848. The webcast will also be available on Inogen’s website for one year following the completion of the call.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

We are a medical technology company offering innovative respiratory products for use in the homecare setting. We primarily develop, manufacture and market innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

Contacts

Investor Relations Contact:
Matthew Pigeon

mpigeon@inogen.net

Staff

Recent Posts

New National Alliance Launches to Address Health Workforce Shortages in Underserved Communities

WASHINGTON, D.C. / ACCESS Newswire / December 15, 2025 / Leading national organizations have come…

2 hours ago

Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million

We remain on track to deliver year-over-year revenue growth and to generate positive adjusted EBITDA…

2 hours ago

TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

HighlightsNewly granted patent protects TempraMed's VIVI Box™ proprietary, hassle-free thermal-insulation system and smart-monitoring architectureExpands the…

3 hours ago

Functional Brands Announces Third Quarter 2025 Financial Results

Lake Oswego, Oregon--(Newsfile Corp. - December 15, 2025) - Functional Brands Inc. (NASDAQ: MEHA), a…

3 hours ago

ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

TYLER, Texas--(BUSINESS WIRE)--ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a medical technology company…

8 hours ago